Insights

Innovative Biotech Focus Surrozen specializes in regenerative medicines by targeting the Wnt signaling pathway, positioning it at the forefront of cutting-edge biotechnology innovations that could benefit from advanced research tools and collaboration platforms.

Strong Investor Backing With a substantial funding of 83 million dollars and annual revenues between 25 to 50 million dollars, Surrozen demonstrates financial stability and growth potential, making it an attractive partner for suppliers of biotech development or clinical trial services.

Expert Research Team Founded by renowned scientists from prestigious institutions, the company maintains a highly skilled research team that could benefit from specialized laboratory equipment, data management solutions, and scientific collaboration tools.

Market Expansion Potential As a biotechnology firm targeting regenerative medicine, Surrozen presents opportunities for sales of advanced bioprocessing technologies, therapeutic development platforms, and market access solutions to support its innovation pipeline.

Tech Stack and Infrastructure Utilizing modern web technologies and research tools such as Benchling and SAP systems, Surrozen is likely to invest in cutting-edge informatics, cloud solutions, and cybersecurity services to support its R&D activities.

Surrozen Tech Stack

Surrozen uses 8 technology products and services including jQuery CDN, Benchling, jQuery Migrate, and more. Explore Surrozen's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Benchling
    Health Platform
  • jQuery Migrate
    Javascript Libraries
  • Web Vitals
    Javascript Libraries
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Akamai Web Application Protector
    Security
  • GraphPad Prism
    Visualisation Software
  • OpenResty
    Web Servers

Media & News

Surrozen's Email Address Formats

Surrozen uses at least 1 format(s):
Surrozen Email FormatsExamplePercentage
First@surrozen.comJohn@surrozen.com
73%
FLast@surrozen.comJDoe@surrozen.com
18%
Last@surrozen.comDoe@surrozen.com
6%
FiLast@surrozen.comJoDoe@surrozen.com
3%

Frequently Asked Questions

Where is Surrozen's headquarters located?

Minus sign iconPlus sign icon
Surrozen's main headquarters is located at 171 Oyster Point Boulevard South San Francisco, California 94080 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Surrozen's stock symbol?

Minus sign iconPlus sign icon
Surrozen is a publicly traded company; the company's stock symbol is SRZNW.

What is Surrozen's official website and social media links?

Minus sign iconPlus sign icon
Surrozen's official website is surrozen.com and has social profiles on LinkedInCrunchbase.

What is Surrozen's SIC code NAICS code?

Minus sign iconPlus sign icon
Surrozen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Surrozen have currently?

Minus sign iconPlus sign icon
As of February 2026, Surrozen has approximately 70 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Operating Officer: C. W.Chief Medical Officer: G. V.Vp Of Information Technology & Site Operations: D. N.. Explore Surrozen's employee directory with LeadIQ.

What industry does Surrozen belong to?

Minus sign iconPlus sign icon
Surrozen operates in the Biotechnology Research industry.

What technology does Surrozen use?

Minus sign iconPlus sign icon
Surrozen's tech stack includes jQuery CDNBenchlingjQuery MigrateWeb VitalsSAP Maintenance, Repair, and OverhaulAkamai Web Application ProtectorGraphPad PrismOpenResty.

What is Surrozen's email format?

Minus sign iconPlus sign icon
Surrozen's email format typically follows the pattern of First@surrozen.com. Find more Surrozen email formats with LeadIQ.

How much funding has Surrozen raised to date?

Minus sign iconPlus sign icon
As of February 2026, Surrozen has raised $83M in funding. The last funding round occurred on Jun 19, 2020 for $50M.

Surrozen

Biotechnology ResearchCalifornia, United States51-200 Employees

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm.

We are currently seeking highly creative scientists to join our team, and invite you to explore career opportunities on our website.

Section iconCompany Overview

Headquarters
171 Oyster Point Boulevard South San Francisco, California 94080 United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SRZNW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $83M

    Surrozen has raised a total of $83M of funding over 2 rounds. Their latest funding round was raised on Jun 19, 2020 in the amount of $50Mas a Series C.

  • $25M$50M

    Surrozen's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $83M

    Surrozen has raised a total of $83M of funding over 2 rounds. Their latest funding round was raised on Jun 19, 2020 in the amount of $50Mas a Series C.

  • $25M$50M

    Surrozen's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.